La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pimavanserin as treatment for Parkinson's disease psychosis.

Identifieur interne : 000971 ( Main/Exploration ); précédent : 000970; suivant : 000972

Pimavanserin as treatment for Parkinson's disease psychosis.

Auteurs : Susan H. Fox [Canada]

Source :

RBID : pubmed:24183566

English descriptors


DOI: 10.1016/S0140-6736(13)62157-1
PubMed: 24183566


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pimavanserin as treatment for Parkinson's disease psychosis.</title>
<author>
<name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name>
<affiliation wicri:level="1">
<nlm:affiliation>Movement Disorder Clinic, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada M5T 2S8. Electronic address: sfox@uhnresearch.ca.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Movement Disorder Clinic, University Health Network, Toronto Western Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24183566</idno>
<idno type="pmid">24183566</idno>
<idno type="doi">10.1016/S0140-6736(13)62157-1</idno>
<idno type="wicri:Area/PubMed/Corpus">000790</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000790</idno>
<idno type="wicri:Area/PubMed/Curation">000790</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000790</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000790</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000790</idno>
<idno type="wicri:Area/Ncbi/Merge">001605</idno>
<idno type="wicri:Area/Ncbi/Curation">001605</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001605</idno>
<idno type="wicri:Area/Main/Merge">000973</idno>
<idno type="wicri:Area/Main/Curation">000971</idno>
<idno type="wicri:Area/Main/Exploration">000971</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pimavanserin as treatment for Parkinson's disease psychosis.</title>
<author>
<name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name>
<affiliation wicri:level="1">
<nlm:affiliation>Movement Disorder Clinic, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada M5T 2S8. Electronic address: sfox@uhnresearch.ca.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Movement Disorder Clinic, University Health Network, Toronto Western Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Lancet (London, England)</title>
<idno type="eISSN">1474-547X</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Parkinson Disease (psychology)</term>
<term>Piperidines (therapeutic use)</term>
<term>Psychotic Disorders (drug therapy)</term>
<term>Serotonin 5-HT2 Receptor Agonists (therapeutic use)</term>
<term>Urea (analogs & derivatives)</term>
<term>Urea (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Urea</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Antipsychotic Agents</term>
<term>Piperidines</term>
<term>Serotonin 5-HT2 Receptor Agonists</term>
<term>Urea</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000971 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000971 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24183566
   |texte=   Pimavanserin as treatment for Parkinson's disease psychosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24183566" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022